Announcements Trials
Browse Landscape

Phase

Phase 2 47Phase 3 14Phase 1/2 6Phase 1 3Phase NA 2Phase 4 2Phase 2/3 1

Status

Completed 3

Sponsor Class

NIH 4OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Other solid neoplasm 1

Conditions

Urinary Bladder Neoplasms 1Urethral Neoplasms 1Mesothelioma, Malignant 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Interferon-alpha × Clear all
NCT00082719 2015-05-14

Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium

M.D. Anderson Cancer Center

Phase 1 Completed
33 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00045370 2013-06-05

Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003263 2013-04-17

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Fox Chase Cancer Center

Phase 1 Completed
6 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡